Delivery Order SPE2DB22D3301-SPE2DB25FX4KE

Award Date 10/25/24
Potential Completion Date 11/18/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $10,641.84 and is a delivery order for the supply of PHESGO 600-600 mg-20,000 unit 10 ml medical products. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,641.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO, a medical product, with a completion date of October 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA, potentially worth up to $999,999,999, for the supply of a broad range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,009.64 Firm Fixed Price Delivery Order is for the supply of the drug PHESGO 600-600 MG-20,000 UNIT 10ML, with a period of performance through January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML medical products. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 7, 2025. The contract is not designated as a set-aside and is considered an open competition award. AmerisourceBergen...
This federal contract award is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,320.92 and a performance period through May 6, 2024. The contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award summarized here was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,105.26 firm fixed-price delivery order is for the supply of 30,000 units of the drug PHESGO (1,200-600mg 15ml), with an ultimate completion date of October 12, 2022. This award is a task order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $92,861 delivery order contract is for the provision of a variety of pharmaceutical products and medical supplies to support federal healthcare programs. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other medical commodities across multiple therapeutic areas. The award is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceuticals. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,753.16 firm fixed-price delivery order contract covers the supply of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,205.34 firm-fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of October 22, 2024....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4KE
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products. The $10,641.84 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers a variety of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 1/24/25, 9:10 AM